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OBJECTIVES To test whether left ventricular (LV) dysfunction affecting type 1 diabetic-uremic patients was
associated with abnormal heart high-energy phosphates (HEPs) and to ascertain whether
these alterations were also present in recipients of kidney or kidney-pancreas transplantation.
BACKGROUND Heart failure is the major determinant of mortality in patients with diabetic uremia. Both
uremia and diabetes induce alterations of cardiac HEPs metabolism.
METHODS Magnetic resonance imaging and phosphorous magnetic resonance spectroscopy of the LV
were performed in the resting state by means of a 1.5-T clinical scanner. Eleven diabetic-
uremic patients, 5 nondiabetic patients with uremia, 11 diabetic recipients of kidney
transplantation, and 16 diabetic recipients of combined kidney-pancreas transplantation were
studied in a cross-sectional fashion. Eleven nondiabetic recipients of kidney-only transplant
and 13 healthy subjects served as control groups.
RESULTS Uremic patients had higher LV mass, diastolic dysfunction, and lower phosphocreatine
(PCr)/adenosine triphosphate (ATP) ratio in comparison with recipients of kidney-pancreas
or nondiabetic recipients of kidney transplant. In diabetic recipients of kidney transplant the
PCr/ATP ratio was higher than in uremic patients but was lower than in the controls.
Recipients of combined kidney-pancreas transplant had a higher ratio than uremic patients
but no difference was found in comparison with controls.
CONCLUSIONS Altered resting myocardial HEPs metabolism may contribute to LV dysfunction in
diabetic-uremic patients. In diabetic recipients of kidney transplantation, a certain degree of
LV metabolic and functional impairment was found. In combined kidney-pancreas recipients
the resting LV metabolism and function were not different than in controls. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.075Cardiol 2005;46:1085–92) © 2005 by the American College of Cardiology Foundation
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Sore than a century ago heart failure was regarded as a
frequent and noteworthy complication of diabetes mellitus”
1). Epidemiologic evidence sustaining this observation in
atients with type 1 diabetes became available in the 1970s
2). It is now recognized that heart failure is the major cause
f death (65%) among patients with type 1 diabetes and
his risk is high in those with concomitant uremia (3).
echanisms for myocardial dysfunction include coronary
acro- and microvascular angiopathy and hypertension (4).
owever, a specific cardiomyopathy was suggested as a
ausal factor producing high cardiac mortality and morbid-
ty independent of the aforementioned conditions (5,6), and
t was hypothesized that lipo- and gluco-toxicity may induce
ltered cardiac function in patients with diabetes (7).
From the *Division of Internal Medicine-Section of Nutrition/Metabolism, †Unit
f Clinical Spectroscopy, ‡Internal Medicine-Section of Organ Transplantation,
Division of Diagnostic Radiology, Division of Nuclear Medicine, Universitá Vita e
alute San Raffaele, Milan, Italy; and the ¶Faculty of Exercise Sciences, Universitá
egli Studi di Milano, Milan, Italy. This work was supported by grants from the
talian Ministry of Health (RF02.199). Drs. Perseghin and Fiorina contributed
qually to this work.w
Manuscript received January 10, 2005; revised manuscript received May 23, 2005,
ccepted May 24, 2005.Localized phosphorous-31 magnetic resonance spectroscopy
31P-MRS) has been used to study the left ventricular (LV)
igh-energy phosphates (HEPs) in vivo in humans (8,9): The
erived phosphocreatine (PCr)/adenosine triphosphate (ATP)
atio is considered the index of energy metabolism and the
hosphate potential (energy charge) of the myocardium (10).
We hypothesized that the alterations of cardiac function
n patients with type 1 diabetes and uremia might be due to
mpaired cardiac energy metabolism and that the cure of
hronic hyperglycemia and uremia might induce improve-
ents of these abnormalities. This study was undertaken: 1)
o test whether the abnormal LV diastolic function of type 1
iabetic-uremic patients was associated with abnormal PCr/
TP ratio, and 2) to ascertain the effects of kidney transplan-
ation alone and/or combined kidney-pancreas transplantation
n heart function and metabolism using noninvasive cardiac
agnetic resonance imaging (MRI) and 31P-MRS.
ETHODS
ubjects. STUDY SUBJECTS. Study subjects were recruited
ithin the Section of Organ Transplantation of the Istituto
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linical and nutritional conditions. The main criteria for
xclusion from the study were: 1) history of coronary,
erebral, or peripheral vascular events; 2) history of dilated
ardiomyopathy; 3) previous knowledge of a pathologic
jection fraction; 4) previous knowledge of resting electro-
ardiographic (ECG) markers of cardiac ischemia; and 5)
eatures compatible with the New York Heart Association
NYHA) functional classes for heart failure. To assess the
ombined effects of type 1 diabetes and kidney failure on
ardiac HEPs metabolism and the effect of kidney failure
lone, 11 type 1 diabetic-uremic patients and 5 nondiabetic
remic patients were selected. They were on the waiting list
f our institute for receiving combined kidney-pancreas
ransplantation (diabetic patients) or kidney transplantation
lone (nondiabetic patients). Eleven diabetic recipients of
idney transplantation only (owing to macroscopic damage
f the pancreas at the time of organ harvest) and 16 diabetic
ecipients of combined kidney-pancreas transplantation also
Abbreviations and Acronyms
E/A ratio  E-peak filling rate/A-peak filling rate ratio
ECG  electrocardiogram/electrocardiographic
HEPs  high-energy phosphates
LV  left ventricle
MRI  magnetic resonance imaging
NYHA  New York Heart Association
PCr/ATP  phosphocreatine/adenosine triphosphate
31P-MRS  phosphorous-31 magnetic resonance
spectra/spectroscopy
rCRSD  relative Cramer-Rao standard deviation
able 1. Anthropometric and Laboratory Parameters of Study G
Diabetic-Uremic
Patients
Nondiabetic
Uremic Patients
umber of patients (F/M) 11 (3/8) 5 (0/5)
ge (yrs) 44  2 38  5
ody mass index (kg/m2) 23.3  1.2 21.2  1.6
urface area (m2) 1.75  0.26 1.75  0.05
uration of dialysis (yrs) 2.2  0.6 2.1  0.9
ransplant age (yrs) — —
uration of diabetes (yrs) 30  3† —
lycated hemoglobin (%) 9.0  0.6*†‡ 4.1  0.3
reatinine (mg/dl) 7.2  0.5*†§ 6.3  0.9*†§
icroalbuminuria nd nd
otal cholesterol (mg/dl) 206  15 176  28
riglycerides (mg/dl) 121  22 187  22
ystolic blood pressure
(mm Hg)
133  6 140  12
iastolic blood pressure
(mm Hg)
76  7 85  6
atients on antihypertensive
drugs (%)
65% 100%
etinopathy (%) 100% —
europathy (%) 100% —ne-way analysis of variance and Tukey’s post-hoc test. *p  0.01 vs. recipients of combin
ransplantation. ‡p  0.05 vs. non-diabetic uremic patients. §p  0.05 vs. diabetic recipieere studied to assess cardiac HEPs metabolism in trans-
lanted patients.
ONTROL SUBJECTS. To control the effects of immunosup-
ression and of diabetes, an additional group of 10 nondi-
betic patients with uremia were studied after receiving
idney transplantation alone and 13 healthy individuals
atched for age and body mass index with the other study
roups served as controls without history of diabetes and
remia. Finally, to compare the severity of the LV abnor-
alities detected in our study groups with that of a group of
ndividuals with overt systolic dysfunction, 11 individuals
ith known heart failure determined by means of standard
chocardiography were recruited. Characteristics of study
roups are summarized in Table 1. In all transplanted
atients, immunosuppression was maintained using cyclo-
porine, mycophenolate mofetil, or azathioprine. Recipients
f combined kidney-pancreas transplantation were insulin
ndependent, whereas diabetic-uremic patients and diabetic
ecipients of kidney transplantation were on subcutaneous
nsulin therapy. Blood pressure was taken twice in the
itting position and after 10 min rest with a sphyngoma-
ometer. Informed consent was obtained from all subjects
fter explanation of purposes, nature, and potential risks of
he study. The protocol was approved by the ethical com-
ittee of the Istituto Scientifico H San Raffaele.
xperimental protocol. Patients were instructed to con-
ume an isocaloric diet and to abstain from exercise activity
or two weeks before the study. Patients took all of their
edications and subcutaneous insulin according to the
egular schedule. All patients underwent the 31P-MRS
Diabetic
cipients of
Kidney
nsplantation
Recipients of
Combined
Kidney-Pancreas
Transplantation
Nondiabetic
Recipients of
Kidney
Transplantation Normal
11 (3/8) 16 (6/10) 11 (3/8) 13 (2/11)
8  3 39  2 46  4 42  5
.9  0.8 22.4  0.7 22.4  0.7 23.8  0.5
6  0.19 1.79  0.21 1.72  0.08 1.89  0.22
.2  0.9 2.9  0.5 1.3  0.3 —
.2  1.2 3.5  0.7 4.0  0.6 —
1  2 25  2 — —
.6  0.5*†‡ 5.6  0.2 5.6  0.2 5.0  0.3
.0  0.2 1.4  0.2 1.5  0.2 0.9  0.2
8  7 15  5 15  2 nd
6  15 177  9 172  12 181  4
1  18 92  7†‡§ 211  48 83  5
1  6 128  5 133  3 125  3
3  2 79  2§ 81  2 81  2
91% 73% 82% 0%
100% 100% — —
100% 100% — —roups
Re
Tra
4
23
1.7
3
3
3
8
1
1
20
14
14
8ed kidney-pancreas transplantation. †p  0.01 vs. non-diabetic recipients of kidney
nts of kidney transplantation. p  0.05 vs. normals.
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September 20, 2005:1085–92 Cardiac HEPs After Kidney-Pancreas Transplantrotocol at 4:00 PM on Thursdays. Seven diabetic-uremic
atients, four nondiabetic uremic patients, seven diabetic
ecipients of kidney transplantation, nine recipients of
ombined kidney-pancreas transplantation, and nine non-
iabetic uremic recipients of kidney-only transplantation
erformed the MRI protocol in the same session or the
ollowing Thursday. Uremic patients performed the studies
he day after the dialysis session.
1P-MRS PROTOCOL. Cardiac 31P-MRS and MRI were
erformed at rest with the use of a 1.5-T whole-body
canner (Gyroscan Intera Master 1.5 MR System; Philips
edical Systems, Best, the Netherlands). 31P spectra were
btained by means of a 10-cm-diameter surface coil used for
ransmission and detection of radio frequency signals at the
esonance frequency of 31P (at 1.5 T, 25.85 MHz) as
escribed by Lamb et al. (11). The surface coil was secured
n place with a Velcro band around the chest. The ECG-
riggered MRI was performed to acquire scout images, to
stablish the exact position of the 31P surface coil, and
ventually to reposition the coil center just below the mitral
alve level of the heart. Localized homogeneity adjustment
as performed using the body coil and ECG-triggering by
ptimizing the 1H-MRS water signal. Shim volumes were
lanned on the transverse and sagittal scout images to
nclude the entire LV. The transmitter-receiver was then
witched without time delay to the 31P frequency. Manual
uning and matching of the 31P surface coil was performed
o adjust for different coil loading. The radio frequency level
as adjusted to obtain a 180° pulse of 40 s for the reference
ample at the center of the 31P surface coil. The acquisition
f 31P-MR spectra was triggered to the R-wave of the
CG, with a trigger delay time of 200 ms and a recycle time
f 3.6 s. The image-selective in vivo spectroscopy (ISIS)
olume selection in three dimensions (3D-ISIS) based on
92 averaged free induction decays was employed. The
olume of interest was oriented avoiding inclusion of chest
all muscle and diaphragm muscle. The volume size was
ypically 6 (caudo-cranial)  7  7 cm3. Acquisition time
as 10 min. Adiabatic frequency-modulated hyperbolic secant
ulses and adiabatic half-passage detection pulses were used to
chieve inversion and excitation over the entire volume of
nterest. Examination time was 40 to 45 min. Three-
imensional ISIS was employed after testing that the PCr/
TP ratios were in close agreement using higher spatial
esolution (two-dimensional ISIS one-dimensional spectro-
copic imaging using a one-dimensional phase encoding bar
ith 32 rows of 1 cm thickness).
RI PROTOCOL. MRI studies were performed with the
canner just described using an enhanced gradient system
ith a maximum gradient strength of 30 mT/m and a
aximum gradient slew rate of 150 mT · m1 · s1. The
ardiac Research software patch (operating system 9) was
sed. The examination was performed using a five-element
ardiac phased-array coil (SENSE-cardiac) and retrospec-
ive ECG-triggering obtained with the vectorcardiogram aystem (12) using standard MRI methodology. Briefly, cine
ong-axis, four-chamber, and two-chamber views were ob-
ained using balanced fast field echo breath-hold sequence
bFFE/BH), and a volumetric evaluation in a three-
imensional fashion was obtained (13). Flow mapping of
he transmitral flow was performed with an ECG-gated,
uantitative flow measurement, two-dimensional, phase-
ontrast, fast field echo sequence oriented perpendicular to
he transmitral flow, and parameters of diastolic function
ere calculated (14). The entire MRI protocol lasted 30
in.
Analytical high-density lipoprotein cholesterol, and tri-
lycerides were measured as previously described (15).
ow-density lipoprotein cholesterol was calculated using
he Friedwald formula (16).
alculation. 31P-MRS ANALYSIS. The 31P-MRS were
ransferred to a remote SUN-SPARC workstation (SUN
icrosystems Inc., Santa Clara, California) for analysis.
he spectra (Fig. 1) were quantified automatically in the
ime domain, using Fitmasters. The ATP level was cor-
ected for the ATP contribution from blood in the cardiac
hambers based on a previous study (17). Depending on the
epetition time (TR), PCr/ATP ratios had to be corrected
or partial saturation effects and T1 values obtained from
nversion recovery experiments on the human LV were used.
ased on these data and a repetition time of 3.6 s, a
aturation correction factor of 1.35 was obtained and ap-
lied to all “blood corrected” myocardial PCr/ATP ratios
11,18). An estimate of the signal-to-noise-ratio of each
pectrum was obtained from the relative Cramer-Rao stan-
ard deviation (rCRSD) calculated for the PCr/ATP,
hich is a commonly reported index of accuracy of the
pectral quantification (11). The 31P-MRS with an rCRSD
20% were excluded and the experiment was repeated to
btain a better spectrum.
RI ANALYSIS. Image analysis was performed by an image-
rocessing workstation (EasyVision; Philips Medical Sys-
ems) using the cardiac analysis software package. The
ndocardial contours of the LV were traced manually by an
xperienced cardioradiologist on all cardiac phases of the 10
hort-axis orientation slices, and epicardial contours were
raced on telediastolic phases. The surface areas of the
ndocardial tracings in end-diastole and end-systole were
utomatically summed up and multiplied by parameters
elative to the section thickness to produce the end-diastolic
nd end-systolic volumes. From this analysis the stroke
olume, cardiac output, and ejection fraction were automat-
cally measured (Table 2). The LV mass was calculated
ultiplying the wall volume by the specific density of
ardiac muscle (1.05 g/cm3) (19). For the assessment of the
iastolic function the mitral orifice area was manually traced
n the magnitude images and automatically transferred to
he velocity phase images by A. E. and F. D. C. The
orphology and the size of each contour were adjustedccording to the cardiac phase. The mean flow (ml/s) was
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utomatically, curves of flow rate versus time were recon-
tructed. From this analysis we measured the E and A
eaks features and volumes (Table 3).
tatistical analysis. All data are presented as mean 
EM. Analyses were performed using SSPS software (ver-
ion 10.0; SPSS, Chicago, Illinois). Comparisons between
roups were performed using one-way analysis of variance
igure 1. Scout images in the transverse (A) and sagittal (B) image planes
he three-dimensional ISIS volume. In panel C, the 31P-spectrum show
hosphodiesters (PDE), and the combined signals of 2,3-diphosphoglycer
able 2. Left Ventricular Morphology and Systolic Function
Diabetic-Uremic
Patients
Nondiabetic
Uremic Patients
umber of patients (F/M) 7 (1/6) 4 (0/4)
V mass (g) 180  25*‡ 185  24*†
VMI (g/m2) 91  22 106  28*‡
nd-diastolic volume (ml) 131  14*‡ 140  26*†
nd-systolic volume (ml) 53  6*‡ 48  12*
troke volume (ml) 79  8 92  18
jection fraction (%) 60  1 69  5
ardiac output (l/min) 6.1  0.6 6.1  1.3
eart rate (beats/min) 78  3 65  5
ne-way analysis of variance and Tukey’s post-hoc test. *p  0.01 vs. recipients of c
ransplantation. ‡p  0.05 vs. normals.
LV  left ventricular; LVMI  left ventricular mass index.nd Tukey’s post hoc tests. Linear regression analysis was
sed to determine the association between PCr/ATP ratio
nd uremia, diabetes, and the LV mass index separately.
tepwise multiple regression analysis was performed (using
ratio-to-remove of 4 and F ratio-to-enter of 3.996) to
ssess which of these variables were more relevant. When-
ver it is stated that groups were not different for a specific
ariable, one should bear in mind that with the present
cardiac 31P-spectrum (panel C). In panels A and B, the squares indicate
nance peaks of phosphocreatine (PCr), adenosine triphosphate (ATP),
,3-DPG) originating from blood and inorganic phosphate (Pi).
Diabetic
ecipients of
Kidney
nsplantation
Recipients of
Combined
Kidney-Pancreas
Transplantation
Nondiabetic
Recipients of
Kidney
Transplantation Normal
7 (1/5) 9 (1/8) 9 (1/8) 13 (2/11)
148  23 121  19 140  7 127  24
84  18 68  14 83  11 67  8
113  22 100  13‡ 109  5‡ 135  23
31  13 29  3‡ 34  2‡ 49  12
74  11 72  10 73  7 86  15
67  3 71  2 67  2 63  5
5.4  0.7 4.5  0.3 5.2  0.5 6.0  1.7
75  7 64  5 72  3 69  12
ed kidney-pancreas transplantation. †p  0.01 vs. non-diabetic recipients of kidneyandR
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ifferences might not be sufficient.
ESULTS
atient characteristics (Table 1). Anthropometric fea-
ures of study subjects were not different. Dialysis and
iabetes durations were not different among the appropriate
tudy groups. Patients with diabetes were in poor control as
eflected by the HbA1c level (Table 1), and patients with
remia were characterized by high plasma creatinine. Mi-
roalbuminuria and the lipid profile were not different
mong groups with the exception of plasma triglyceride
hich was higher in nondiabetic uremic patients and
iabetic and nondiabetic recipients of kidney transplanta-
ion in comparison with recipients of combined kidney-
ancreas transplantations and normal subjects. In contrast
ith normal subjects, the majority of patients were taking
ntihypertensive drugs, but blood pressure was not different
mong groups. The 11 individuals with known heart failure
1 female:10 males; age 66  6 yrs; body mass index 27.1 
.4 kg/m2; 6 in NYHA functional class I, 3 in class IIA, and
in class IIB) had ischemic cardiomyopathy (n  8) or
ilated cardiomyopathy (n 3) and had an ejection fraction
f 35  2%, based on standard echocardiography.
natomical and functional assessment of the left ventri-
le (Tables 2 and 3). The LV mass was higher in uremic
atients (Table 2). Larger end-diastolic and end-systolic
olumes were also detected in diabetic-uremic patients in
omparison with recipients of combined kidney-pancreas
ransplantation and nondiabetic recipients of kidney-only
ransplantation. Parameters of systolic function were not
ifferent among groups (Table 2). In contrast, parameters of
iastolic function were altered in diabetic and nondiabetic
remic patients as reflected by the lower E/A ratio when
able 3. Left Ventricular Diastolic Function
Diabetic-Uremic
Patients
Nondiabetic
Uremic
Patients
umber of patients (F/M) 7 (1/6) 4 (0/4)
/A peak flow 1.4  0.3§ 1.4  0.1§
-peak filling rate (ml/s) 422  22*†‡ 456  39*†‡
-peak filling rate/EDV (s1) 3.3  0.5 3.5  0.3
acceleration peak
(ml/s2  103)
6.5  0.5 5.8  1.9
deceleration peak
(ml/s2  103)
3.1  0.4 3.2  0.9
-peak filling rate (ml/s) 364  80*§ 304  29*§
-peak filling rate/EDV (s1) 2.7  0.3§ 2.4  0.4§
acceleration peak
(ml/s2  103)
3.9  0.8 5.1  0.4
deceleration peak
(ml/s2  103)
5.0  1.0*§ 4.6  0.9
eceleration time (ms) 95  24*†‡§ 163  15
ne-way analysis of variance and Tukey’s post-hoc test. *p  0.01 vs. recipients of c
ransplantation. ‡p  0.05 vs. diabetic recipients of kidney transplantation. §p  0.ompared with normal subjects (Table 3). Interestingly, oiabetic recipients of kidney transplantation also showed
bnormalities of the diastolic function in comparison with
ormal subjects (Table 3). Dialysis may induce loading-
ependent modifications of the indices of the LV function
n patients with chronic renal failure. To minimize this issue
he uremic patients were studied the day after dialysis. It is
mportant to state that it is reported that after hemodialysis
ine-MRI did not show a significant change in the ejection
raction but detected 14% to 27% reduction of the end-
iastolic, end-systolic, and stroke volumes; meanwhile LV
ass was reduced by 4% (20); in addition, hemodialysis was
eported to induce a reduction in the E/A ratio and no
hange in the deceleration time (21).
Cr/ATP ratio: accuracy and reproducibility. Mean
CRSD was not different among groups (15  2%, 11 
%, 14  2%, 15  1%, 14  1%, and 14  3% in diabetic
nd nondiabetic uremic patients, diabetic recipients of
idney transplantation, recipients of combined kidney-
ancreas transplantation, nondiabetic recipients of kidney
ransplantation, and normal subjects, respectively). An esti-
ate of intra-examination differences was obtained by
tudying 12 subjects twice and consecutively in the same
ession without changing the position of the surface coil, the
ensitive volumes, and the acquisition parameters. The
oefficient of variation was 4  2%. Interexamination
ariability was studied by examining 8 subjects on two
eparate occasions, with a time interval of 7 to 16 days. No
fforts were made to minimize variability. The coefficient of
ariation was 8  3%.
etabolic assessment of the HEPs of the left ventricle
Fig. 2). The PCr/ATP ratio was not different in diabetic
remic (1.33  0.05) in comparison with nondiabetic
remic (1.42  0.07; p  0.34) patients but was lower in
oth subgroups in comparison with nondiabetic recipients
Diabetic
cipients of
Kidney
nsplantation
Recipients of
Combined
Kidney-Pancreas
Transplantation
Nondiabetic
Recipients of
Kidney
Transplantation Normal
7 (1/5) 9 (1/8) 9 (1/8) 13 (2/11)
1.2  0.2§ 1.6  0.1 1.6  0.3 2.0  0.5
38  23§ 373  25§ 367  30§ 482  103
3.3  0.4 3.8  0.3 3.4  0.4 3.7  0.6
5.9  0.6 5.7  0.6 5.0  0.6 6.3  1.6
2.2  0.3§ 2.8  0.2§ 2.7  0.4§ 3.9  1.1
31  56 236  28 264  31 237  78
3.0  0.3*§ 2.4  0.1§ 2.4  0.3§ 1.8  0.5
4.7  0.7 4.0  0.5 3.9  0.4 4.8  2.4
4.9  1.1*§ 3.3  0.4 3.3  0.7 3.3  1.4
34  19 157  25 163  10 165  26
ed kidney-pancreas transplantation. †p  0.01 vs. non-diabetic recipients of kidney
normals.Re
Tra
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Cardiac HEPs After Kidney-Pancreas Transplant September 20, 2005:1085–92ormal subjects (1.91  0.05; p  0.01). In diabetic
ecipients of kidney transplantation the PCr/ATP ratio was
igher (1.55  0.07) in comparison with uremic patients (p
0.03) but was lower in comparison to the controls (p 
.05). In contrast, recipients of combined kidney-pancreas
ransplantation had a higher ratio (1.68  0.11) in compar-
son with the uremic patients (p  0.02) and no difference
as detected in comparison with control subjects (p  NS).
inear regression analysis (Table 4). Linear regression
nalysis showed that when taken separately the variables
remia, diabetes, and LV mass index were significantly
ssociated with the PCr/ATP ratio. The multiple stepwise
egression analysis selected uremia as the best predictor of
he PCr/ATP ratio; meanwhile, diabetes (p  0.057), and
V mass index (p  0.258) did not add a significant
redictive value.
everity of the HEPs abnormalities (Fig. 3). MRI con-
rmed that patients with overt systolic dysfunction had
educed ejection fraction (38  5%) and stroke volume (61
13 ml; p 0.01 vs. normal subjects) along with increased
V mass (194  25 g; p  0.01 vs. normal subjects) and
iastolic dysfunction (E/A ratio 0.8  0.3; p  0.01 vs.
ormal subjects). The PCr/ATP ratio was significantly
ower when compared with normal subjects (1.36 0.12 vs.
igure 2. Comparison of the left ventricular (LV) phosphocreatine/ATP
PCr/ATP) ratios of diabetic patients with uremia, nondiabetic patients
ith uremia, diabetic-uremic recipients of kidney transplantation (Tx)
lone or combined kidney-pancreas transplantation, nondiabetic uremic
ecipients of kidney transplantation alone, and normal subjects. One-way
nalysis of variance and Tukey’s post-hoc tests.
able 4. Results of the Linear Regression Analysis Between the
Cr/ATP Ratio and Uremia, Diabetes, and LVMI
Variable r p Value
inear regression analysis Uremia 0.40 0.001
Diabetes 0.37 0.003
LVMI 0.36 0.024
tepwise multiple regression analysis
Entered variables Uremia 0.42 0.008
Excluded variables Diabetes — 0.057
LVMI — 0.258aVMI  left ventricular mass index..91  0.05; p  0.01), and the reduction was proportional
o the NYHA functional class of the patients (1.50  0.20
n class I, 1.31  0.12 in class IIA, and 1.0  0.15 in class
IB; r  0.51; p  0.05). The PCr/ATP ratio of diabetic
nd nondiabetic uremic patients (1.33  0.05 and 1.42 
.07, respectively; p  NS) was not different in comparison
ith the individuals with impaired systolic dysfunction.
ISCUSSION
his work demonstrates that the left ventricle functional
bnormalities affecting patients with type 1 diabetes and
remia are associated with reduced myocardial PCr/ATP
atio. In diabetic recipients of kidney-only transplantation,
bnormal parameters of diastolic function were found, and
he PCr/ATP ratio, though higher in comparison with
remic patients, was still lower in comparison with the
ontrol groups. In contrast, in the recipients of combined
idney-pancreas transplantation the PCr/ATP ratio was not
ifferent in comparison with the control groups.
V function and HEPs metabolism in type 1 diabetes
nd uremia. Our type 1 diabetic-uremic patients had left
entricular hypertrophy and diastolic dysfunction (Tables 2
nd 3) as previously reported (22,23). Less severe abnor-
alities also were detected in the nondiabetic uremic
atients, suggesting that uremia per se is associated with the
erangement of the left ventricular function and that dia-
etes may worsen the heart function. The key finding of the
resent work was the discovery of an alteration of the HEPs
ontent in both diabetic and nondiabetic uremic patients as
ssessed by means of 31P-MRS. Similar results were re-
orted in patients with hypertension and left ventricular
ypertrophy; reduced creatine kinase activity and a lower
otal creatine content may sustain these metabolic alter-
igure 3. Comparison of the phosphocreatine/ATP (PCr/ATP) ratios of
he left ventricle of individuals with established left ventricular (LV)
ystolic dysfunction (with ejection fraction 35% at echocardiography),
iabetic patients with uremia, nondiabetic patients with uremia, and
ormal subjects. One-way analysis of variance and Tukey’s post-hoc tests.tions (24), and the reduced PCr/ATP ratio was associated
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September 20, 2005:1085–92 Cardiac HEPs After Kidney-Pancreas Transplantith the progression of heart failure in patients with dilated
nd hypertrophic cardiomyopathy (25). In this study we
ncluded a group of patients with overt impairment of the
jection fraction and ascertained that the severity of the
bnormal HEPs observed in the uremic patients was severe
espite the fact that the systolic function was unaffected
Fig. 3).
V function and HEPs metabolism in transplant recipi-
nts. Diabetic recipients of kidney-only transplantation,
espite the better cardiac morphologic, functional, and
hole-body metabolic features, showed reduced PCr/ATP
atio when compared with nondiabetic recipients of kidney-
nly transplantation and normal subjects, suggesting that
iabetes was associated with the presence of abnormal
ntracardiac HEPs. Combined kidney-pancreas recipients,
n which the renal failure and diabetes were simultaneously
ured, showed a better left ventricular function in compar-
son with the diabetic-uremic patients, and, overall, the
Cr/ATP ratio was not different in comparison with the
ontrol groups.
These results may provide important insights. First, the
bnormalities characterizing the uremic state may be due to
remia per se, and chronic hyperglycemia may be an
ndependent aggravating factor regardless of hypertension.
n fact, the better functional and metabolic parameters
haracterizing combined kidney-pancreas recipients were
ound despite the fact that in these patients hypertension
as also present (Table 1) and an antihypertensive drug
egimen was required as in the diabetic and nondiabetic
remic patients and despite the fact that blood pressure was
ot different among groups. Second, despite better morpho-
ogic, functional, and metabolic parameters in comparison
ith uremic patients, diabetic recipients of kidney-only
ransplantation showed persisting abnormal features, sup-
orting a deleterious effect of diabetes per se (Tables 2 and
, Fig. 2). Third, in combined kidney-pancreas recipients,
he restoration of a normal metabolic milieu was successful
n achieving normal resting left ventricular function and
etabolism despite the immunosuppressive therapy.
athogenic remarks. The difference in prevailing sub-
trates (glucose and fatty acids) in the heart may affect
yocardial HEPs metabolism. Excessive intracellular glu-
ose uptake may down-regulate the expression of fatty
cid-metabolizing genes through peroxisome proliferator-
ctivated receptor-alpha repression (26) and may increase
dvanced glycation end-products with a consequent gener-
tion of reactive oxygen species affecting mitochondrial
unction (27). Excessive intracellular long-chain acyl-CoA
sters may induce heart dysfunction in vivo in animal
odels (28) and in humans (29). Combined 31P-MRS and
H-MRS will give insights to the cardiac HEPs and
riglyceride content simultaneously, exploring the reciprocal
elationships. Glucolipotoxicity has been indicted as a key
actor inducing an initial adaptation and subsequent malad-
ptation of the heart to the diabetic environment (30,31).ethodologic considerations. Because we did not per-
orm angiography, the presence of subclinical atherosclero-
is could not be entirely excluded. The worse functional and
etabolic profile reported in the diabetic recipients of
idney-only transplantation versus the recipients of com-
ined kidney-pancreas transplantation may be due to the
ersistence of the diabetes-induced microangiopathy; in
act, a different endothelial function (32) and ultrastructural
icrovascular features were already reported in these pa-
ients (33). The large volume of interest used in this work
epresents a limitation of the study, and contamination of
lood could not be avoided as performed by using 31P-
patial localization with optimum pointspread function
SLOOP)-MRS (34). Nevertheless, blood correction was
ppropriately performed as classically proposed (30,31) and
he three-dimensional ISIS approach was appropriately
sed to study metabolic alterations involving the entire heart
nd not local abnormalities within a small amount of tissue.
nother limitation of the study was the lack of the perfor-
ance of a stress-test study potentially able to reveal
tronger difference.
onclusions. This work indicates that altered resting myo-
ardial HEPs may contribute to the left ventricular func-
ional alterations observed in type 1 diabetic-uremic pa-
ients. The cure of renal failure explored in diabetic
ecipients of kidney transplantation was associated with
etter parameters of heart function and metabolism; the
ombined cure of uremia and diabetes explored in recipients
f combined kidney-pancreas transplantation was not asso-
iated with a different left ventricular function and HEPs in
omparison with the control groups. A longitudinal study is
arranted to confirm whether these alterations may be
eversed and whether they may be a useful prognostic
arker of heart failure in patients with type 1 diabetes and
remia.
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